Lisinopril angioedema
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril angioedema"
Lisinopril Angioedema: Incidence and Risk Factors
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to treat hypertension but is associated with a risk of angioedema. The reported incidence of lisinopril-induced angioedema ranges from 0.1% to 0.7%, but recent data suggest the true risk may be higher due to underreporting, potentially affecting up to 1.6% of patients, or about 1 in 63 individuals prescribed lisinopril 3589. Angioedema can occur at any time during therapy, from days to years after starting the medication 3569+1 MORE.
Clinical Presentation: Orofacial and Gastrointestinal Angioedema
Orofacial Angioedema Symptoms
Most commonly, lisinopril-induced angioedema presents as swelling of the lips, face, tongue, or buccal mucosa. Symptoms can range from mild swelling to severe cases involving the tongue and upper airway, which may cause respiratory distress and require intensive care 127. While many cases resolve within 1–2 days after discontinuing lisinopril and administering antihistamines or steroids, some cases can be refractory and require prolonged hospitalization and additional treatments such as fresh frozen plasma or specific bradykinin antagonists 1279.
Small Bowel Angioedema: A Rare but Important Manifestation
Lisinopril can also cause isolated angioedema of the small bowel, a rare but often overlooked cause of severe abdominal pain, nausea, vomiting, and diarrhea 3456+2 MORE. This form of angioedema can mimic other gastrointestinal conditions and is frequently misdiagnosed, leading to unnecessary interventions or surgeries. Imaging typically reveals bowel wall thickening and edema, and symptoms usually resolve rapidly after discontinuing lisinopril 3456+2 MORE. Small bowel angioedema can occur soon after starting therapy or after years of use 35610.
Diagnosis and Management of Lisinopril-Induced Angioedema
Diagnosis is based on clinical presentation, temporal association with lisinopril use, and exclusion of other causes. Imaging may be helpful in cases of gastrointestinal involvement 3456+2 MORE. The primary treatment is immediate discontinuation of lisinopril. Most cases resolve with supportive care, including antihistamines and corticosteroids, but severe or refractory cases may require additional therapies such as epinephrine, bradykinin antagonists, or fresh frozen plasma 279.
Importance of Early Recognition
Early recognition of lisinopril-induced angioedema is crucial to prevent morbidity and avoid unnecessary procedures. Both orofacial and gastrointestinal forms can be serious, and continued use of lisinopril after symptom onset can lead to recurrent or worsening episodes 3569+1 MORE. Healthcare providers should maintain a high index of suspicion for angioedema in patients on lisinopril who present with unexplained swelling or abdominal symptoms 3569+1 MORE.
Conclusion
Lisinopril-induced angioedema is a potentially serious adverse effect that can present with orofacial or gastrointestinal symptoms. The true incidence may be higher than previously reported, and both early and late presentations are possible. Prompt discontinuation of lisinopril and supportive care are key to management, and awareness of this complication is essential to avoid unnecessary interventions and improve patient outcomes 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic